Research Reports

Key takeaways

Ms. Yuki Xu appointed acting Chief Accounting Officer effective April 13, 2026, replacing Ms. Hattie He.

Ms. Xu previously served as Associate Director of Financial Reporting at Burning Rock Biotech Limited (Nasdaq: BNR) from 2019 to March 2026.

At BNR, Ms. Xu oversaw U.S. GAAP financial statements, SEC reporting, compliance, internal controls, and investor relations.

Prior to BNR, Ms. Xu worked at KPMG Huazhen LLP from 2014 to 2019, leading U.S. IPO and SOX audits.

Ms. Xu holds a Bachelor of Finance from Guangdong University of Foreign Studies and is a licensed CPA.

Full analysis

The appointment of Ms. Yuki Xu as acting Chief Accounting Officer brings extensive experience in U.S. GAAP financial reporting, SEC compliance, and internal controls to Aurelion Inc. Her prior role at Burning Rock Biotech involved key responsibilities in Nasdaq IPO execution and ongoing regulatory filings, which are directly relevant to Aurelion's obligations as a foreign private issuer filing under Form 20-F. This change ensures continuity in accounting leadership with a professional who has led SOX audits and managed investor relations for U.S.-listed companies. The transition is effective immediately on April 13, 2026, signaling a smooth handover without disclosed disruptions.

AURE · Aurelion Inc.

Summary

Key takeaways

Full analysis